Takara Bio vs Hasbro Which Performs Better?

Takara Bio and Hasbro are two well-known companies that operate in different sectors of the market. Takara Bio focuses on biotechnology and pharmaceutical products, while Hasbro is a multinational toy and board game company. While both companies have experienced fluctuations in their stock prices over the years, they have shown resilience and growth potential in their respective industries. Investors looking to diversify their portfolios may consider investing in both Takara Bio and Hasbro stocks for long-term growth opportunities.

Takara Bio or Hasbro?

When comparing Takara Bio and Hasbro, different investors may prioritize various metrics based on their investment strategies and goals. So, ask yourself what type of investor you are. This will guide you in determining which metrics are most important for your investment decision between Takara Bio and Hasbro.

Dividend Investors:

Dividend investors look for stable and growing income streams, using dividend metrics to assess potential investments. A company's dividend yield essentially measures the size of its dividend relative to the total market value of the company. Takara Bio has a dividend yield of 1.66%, while Hasbro has a dividend yield of 5.39%. Beyond the yield itself, considering the growth and sustainability of these dividends is also crucial. Takara Bio reports a 5-year dividend growth of 0.00% year and a payout ratio of 1886.84%. On the other hand, Hasbro reports a 5-year dividend growth of 2.62% year and a payout ratio of -60.71%.

Value Investors:

Value investors focus on financial metrics to determine a stock's intrinsic value compared to its market value. The Price-to-Earnings (P/E) Ratio links stock price to a company's earnings per share, with Takara Bio P/E ratio at 1085.85 and Hasbro's P/E ratio at -14.14. Another crucial valuation metric is the Price-to-Book (P/B) Ratio, which compares stock price with book value per share. Takara Bio P/B ratio is 1.11 while Hasbro's P/B ratio is 7.04.

Growth Investors:

Growth investors prioritize metrics indicative of a company's expansion potential. Focusing on top-line growth, Takara Bio has seen a 5-year revenue growth of 0.21%, while Hasbro's is -0.01%. Return on Equity (ROE) measures how effectively a company uses equity investment to generate earnings, with Takara Bio's ROE at 0.10% and Hasbro's ROE at -56.92%.

Retail Investors:

Retail investors often consider stock affordability and company familiarity. For example, day low prices are ¥1019.00 for Takara Bio and $64.88 for Hasbro. Over the past year, Takara Bio's prices ranged from ¥930.00 to ¥1290.00, with a yearly change of 38.71%. Hasbro's prices fluctuated between $46.09 and $73.46, with a yearly change of 59.38%. Brand recognition also plays a role, as familiarity with a company can influence investment decisions.